Sponsor of the Day:
Jerkmate
https://www.statnews.com/2026/02/05/corcept-therapeutics-fda-relacorilant-cushings-disease/
A dispute between Corcept Therapeutics, FDA runs deep | STAT
Feb 5, 2026 - Concerns over a potential risk of liver injury induced by the company's treatment, relacorilant, raise doubts.
corcept therapeuticsruns deepdisputefdastat
https://corcept.com/pipeline-and-clinical-trials/
Pipeline and Clinical Trials - Corcept Therapeutics
clinical trialscorcept therapeuticspipeline
https://zlk.com/news/court-preliminary-approves-settlement-against-corcept-therapeutics-incorporated
Court Preliminarily Approves Settlement Against Corcept Therapeutics Incorporated | Levi &...
Dec 16, 2024 - Update Ferraro Family Foundation, Inc. and James L. Ferraro v. Corcept Therapeutics, Inc., et. al., Case No. 3:19-cv-01372-JD (N.D. Cal.): A settlement has...
corcept therapeuticscourtapprovessettlementincorporated
https://robinhood.com/us/en/stocks/CORT/
Corcept Therapeutics: CORT Stock Price Quote & News | Robinhood
View the real-time CORT price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold...
stock price quotecorcept therapeuticsnews robinhoodcort
https://www.prnewswire.com/news-releases/cort-shareholder-alert-hagens-berman-alerts-corcept-therapeutics-cort--investors-to-securities-class-action-following-fda-rejection-and-federal-court-patent-loss-302746597.html
CORT SHAREHOLDER ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities...
Apr 20, 2026 - /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) of the critical...
hagens bermancorcept therapeuticscortshareholderalert